Immunome Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 19.68 M | $416.95 M | 20.24% | 17.37% |
| FMR LLC | 08/13/2026 | 16.99 M | $359.97 M | 0.10% | 15.00% |
| BLACKROCK, INC. | 08/07/2026 | 8.81 M | $186.59 M | 7.80% | 7.77% |
| STATE STREET CORP | 09/22/2026 | 5.49 M | $116.43 M | 1.75% | 4.85% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 5.21 M | $110.40 M | 10.11% | 4.60% |
| REDMILE GROUP, LLC | 08/14/2026 | 4.91 M | $104.08 M | -11.64% | 4.34% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 4.58 M | $97.08 M | -4.32% | 4.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.55 M | $96.44 M | 2.74% | 4.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 4.35 M | $92.09 M | 6.01% | 3.84% |
| ENAVATE SCIENCES GP, LLC | 08/14/2026 | 3.61 M | $76.58 M | 0.00% | 3.19% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.75 M | $58.39 M | 7.58% | 2.43% |
| MORGAN STANLEY | 08/13/2026 | 2.41 M | $51.02 M | -15.26% | 2.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 2.02 M | $42.74 M | 9.01% | 1.78% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.85 M | $38.99 M | -33.45% | 1.63% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.77 M | $37.58 M | -37.97% | 1.57% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 1.72 M | $36.45 M | 1.08% | 1.52% |
| READYSTATE ASSET MANAGEMENT LP | 08/14/2026 | 1.61 M | $34.03 M | 23.35% | 1.42% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.51 M | $32.05 M | 37.31% | 1.34% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.35 M | $28.58 M | 33.96% | 1.19% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 1.35 M | $28.55 M | -2.14% | 1.19% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.25 M | $26.49 M | 13.89% | 1.10% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.00 M | $21.20 M | -36.50% | 0.88% |
| NORTHERN TRUST CORP | 08/13/2026 | 968.35 K | $20.52 M | 7.70% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 886.19 K | $18.78 M | 4.04% | 0.78% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 886.19 K | $18.78 M | 100.00% | 0.78% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 859.08 K | $18.20 M | 1,437.99% | 0.76% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 756.30 K | $16.03 M | 5.57% | 0.67% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 732.51 K | $15.52 M | 0.00% | 0.65% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 719.27 K | $15.24 M | 3.50% | 0.64% |
| NAN FUNG TRINITY (HK) LTD | 07/24/2026 | 714.55 K | $15.14 M | 0.00% | 0.63% |
| CANDRIAM S.C.A. | 08/13/2026 | 680.13 K | $14.40 M | 25.98% | 0.60% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 647.89 K | $13.73 M | -17.11% | 0.57% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 594.20 K | $12.59 M | 47.27% | 0.52% |
| MARSHALL WACE, LLP | 08/13/2026 | 500.54 K | $10.61 M | -66.20% | 0.44% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 439.19 K | $9.31 M | 133.33% | 0.39% |
| ALERUS FINANCIAL NA | 08/14/2026 | 383.42 K | $8.12 M | 100.00% | 0.34% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 378.54 K | $8.02 M | 23.30% | 0.33% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 367.97 K | $7.80 M | 1,001.43% | 0.32% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 359.78 K | $7.62 M | -0.78% | 0.32% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 347.67 K | $7.37 M | 0.00% | 0.31% |
| UBS GROUP AG | 08/13/2026 | 328.49 K | $6.96 M | -24.12% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 298.87 K | $6.33 M | 8.26% | 0.26% |
| ATOM INVESTORS LP | 08/14/2026 | 297.49 K | $6.30 M | -3.06% | 0.26% |
| NUVEEN, LLC | 08/11/2026 | 288.92 K | $6.12 M | -5.35% | 0.26% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 277.06 K | $5.87 M | -3.47% | 0.24% |
| TOROSO INVESTMENTS, LLC | 08/13/2026 | 268.17 K | $5.68 M | -2.80% | 0.24% |
| TEMA ETFS LLC | 07/10/2026 | 268.17 K | $5.68 M | -2.80% | 0.24% |
| ATIKA CAPITAL MANAGEMENT LLC | 08/13/2026 | 262.90 K | $5.57 M | 0.00% | 0.23% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 262.82 K | $5.57 M | 100.00% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 251.10 K | $5.32 M | 264.43% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunome Inc institutional Ownership - FAQ's
During the previous two years, 251 institutional investors and hedge funds held shares of Immunome Inc. The most heavily invested institutionals were:
Versant Capital Management, Inc: 23
T. Rowe Price Investment Management, Inc.: 19.68 M
FMR LLC: 16.99 M
BlackRock, Inc.: 8.81 M
STATE STREET CORP: 5.49 M
WELLINGTON MANAGEMENT GROUP LLP: 5.21 M
104.99% of Immunome Inc stock is owned by institutional investors.
Institutional investors have bought a total of 130.46 M shares in the last 24 months. This purchase volume represents approximately $2.78 B in transactions.